Solara board meeting on Oct 16 to consider Q2 FY26 results

Revenue growth above 20%EBITDA margin expansionExceptional itemResults View source PDF Explain this filing

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.5%Reaction day

₹645.80

prior close

₹640.60

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+1.7% vs market

Pharmaceuticals peers, median of 167sector-0.1%+2.7% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+1.3

15m

+2.1

30m

+2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.5+0.8+1.7-0.1+2.7

Next day

+1.9+1.0+0.8-0.1+2.0

-0.9+1.7-2.7-0.2-0.7

+0.3+0.1+0.3-1.0+1.3

+9.9+0.8+9.2-0.8+10.8

+0.1-0.9+1.0-2.3+2.4

-3.7-4.5+0.8-4.7+1.0

15d

-2.9-4.8+1.9-2.6-0.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Solara Active Pharma Sciences has informed BSE that its Board of Directors will meet on Friday, October 16, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The trading window for insiders is closed from October 1, 2026, until 48 hours after the results are announced.

Likely market impact

Routine regulatory intimation; no new financial information. Watch for the Q2 results on October 16 for actual performance cues.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹417.3 Cr	₹313.5 Cr	+33.1%
Operating profit	₹32.42 Cr	−₹10.59 Cr	turned positive
Profit after tax	₹28.46 Cr	−₹10.10 Cr	turned positive
EBITDA margin	17.3%	11.1%	+6.2 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.